Outcomes and Risk Factors in Patients with Hematologic Malignancies Following Late-Stage SARS-CoV-2 Infection
In the late stage of the COVID-19 pandemic, active disease status, recent HSCT, and severe/critical SARS-CoV-2 infection significantly increased the risks of disease progression and mortality in HM patients. Higher baseline platelet counts were associated with improved outcomes.
Authors
- Jiang Liu (ORCID: https://orcid.org/0000-0002-4409-1157)
- Bozheng Zhang (ORCID: https://orcid.org/0000-0003-1199-2175)
- Ruijuan Zhang (ORCID: https://orcid.org/0000-0003-1147-9240)
- Junyan Zhang (ORCID: https://orcid.org/0000-0002-7890-3707)
- Lina Wang (ORCID: https://orcid.org/0000-0003-3665-5706)
- Yafang Guo (ORCID: https://orcid.org/0000-0002-0547-3160)
- Meiling Zhao
Institutions
- Florida State University (US)
- Emory University (US)
- Shanxi Medical University (CN)
- Shanxi Academy of Medical Sciences (CN)
Publication Details
- Journal
- Journal of Multidisciplinary Healthcare
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/jmdh.s491098
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00